5-Amino-1MQ

5-Amino-1MQ

5-Amino-1MQ is a small-molecule research compound studied for its role in cellular methylation pathways and metabolic regulation. It is primarily evaluated for its interaction with nicotinamide N-methyltransferase (NNMT), an enzyme involved in NAD⁺ metabolism and energy balance signaling within research models.

Compound Profile

Research Name: 5-Amino-1MQ
Alias: 5A1MQ, NNMT Inhibitor
Category: Small-molecule metabolic modulator
Primary Research Focus: NNMT pathway analysis, NAD⁺ regulation, adipocyte metabolism
Format: Lyophilized powder

Reconstitution & Concentration

Upon reconstitution with an appropriate volume of bacteriostatic water, final concentration will vary based on total diluent added. Researchers calculate concentration using the standard formula:

Total mg in vial ÷ Total mL added = mg per mL

For U-100 insulin syringes:

1 mL = 100 units

Units required are determined by dividing the desired mg amount by the final mg/mL concentration.

Free Dosage Calculator

Research Applications

5-Amino-1MQ is studied for its potential influence on:

• NNMT enzymatic activity

• NAD⁺ availability and methylation balance

• Cellular energy expenditure pathways

• Adipocyte differentiation and lipid signaling

• Body-composition trend analysis in metabolic models

Its mechanism centers around enzyme modulation rather than receptor agonism, differentiating it from incretin-based metabolic compounds.

Monitoring Considerations

Within research environments, investigators may observe:

Dose-dependent variables

• Changes in energy balance markers

• Appetite-related behavioral trends

• Metabolic rate fluctuations

Metabolic & hydration variables

• Caloric intake shifts

• Body-composition changes

• Fluid balance considerations

Less frequent observations

• Mild gastrointestinal discomfort

• Headache

• Injection-site irritation (if applicable to study design)

Monitoring intensity depends on study structure, duration, and whether 5-Amino-1MQ is evaluated independently or alongside other metabolic agents.

Protocol Framework (Research Context)

Administration Frequency: Varies by protocol design
Common Study Duration: 4–12 weeks
Titration Strategy: Gradual adjustments to evaluate tolerance and metabolic response

Researchers typically avoid stacking with other NNMT-modulating compounds to prevent overlapping pathway effects unless specifically designing combination studies.

Storage & Handling

Store lyophilized vial in a cool, dry environment.
Refrigerate after reconstitution.
Maintain sterile laboratory handling procedures at all times.